Diasorin SpA (OTCPK:DSRLF)
$ 109 0 (0%) Market Cap: 5.40 Bil Enterprise Value: 6.37 Bil PE Ratio: 30.77 PB Ratio: 3.12 GF Score: 98/100

Q3 2023 DiaSorin SpA Earnings Call Transcript

Nov 03, 2023 / 03:30PM GMT
Release Date Price: $87.45
Operator

Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the DiaSorin 9 Months 2023 Results Conference Call. (Operator Instructions)

At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.

Carlo Rosa
DiaSorin S.p.A. - CEO, GM & Executive Director

Thank you, operator, and good morning, good afternoon, and welcome to the Q3 conference call. As usual, I'm going to give some comments. At constant exchange rate, about the 3 legs of the business, the Immunodiagnostic, the Molecular Diagnostic and the Licensed Technology, and then I will let our CFO go through the numbers.

So if we start from the overall results, the quarter was in line with our expectation. Growth excluding COVID at constant exchange rate, it was 2% in the quarter, over 3% year-to-date. So it's in line with guidance and expectations, although if we look at the 3 legs of the business, we have different results.

So let's start from the Immunodiagnostics. Immunodiagnostics

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot